Cortexyme Inc. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$2.20

+0 (+0%)

At Close: Nov 04, 2022

Currently predicting for Mon, 6 May 2024

CRTX Predictions History

2 years ago
JS predicted that CRTX for 2022-03-03 is going $4.69 (9.07%)

2 years ago
lhamotopgyal.263000 predicted that CRTX for 2022-03-03 is going

Rank:

2 years ago
Anthony Harriman predicted that CRTX for 2022-03-03 is going

Rank:

2 years ago
Andrea Winder predicted that CRTX for 2022-03-03 is going

Rank:

2 years ago
JS predicted that CRTX for 2022-01-07 is going $11.90 (-1.24%)

2 years ago
prinzipisch.286103 predicted that CRTX for 2022-01-07 is going

Rank:

2 years ago
JS predicted that CRTX for 2021-07-16 is going $50.99 (-4.76%)

2 years ago
sounder predicted that CRTX for 2021-07-16 is going $55.02 (5.81%)

Rank:

About Cortexyme Inc.

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis... CRTX Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

Cortexyme Inc. Stock Predictions

CRTX Predictions History

About Cortexyme Inc.

Golden Star

Top Fintech Company